Maximizing product and portfolio value through the commercial lifecycle
Lifecycle management (LCM) is a dynamic forward-looking process. Datamonitor Healthcare Consulting provides brand-level LCM advice and supports companies on a wide range of portfolio-level projects. The resulting LCM plan captures your key organizational priorities, serving as a roadmap that can be executed across departmental lines for intermediate and long-term returns on investment.
Pre-Launch: When preparing to commercialize a product, there are many opportunities to maximize gains and establish processes and systems that enable you to optimize value at later stages.
Growth Stage: During the patented period, critical to maximizing your investment is understanding future opportunities and threats to growth. We carry out assessments to help you understand how the environment has changed since post-Phase III planning. We also assess the impacts for future LCM planning, specifically assessing follow-on indications, reformulations, and fixed dose.
Late Stage: At loss of exclusivity, it is vital to engage the most profitable tactics for competing with generics or biosimilars. We provide a prioritized list of tactics which are framed around the geographical and environmental context (ie level of stakeholder influence post loss of expiry, generic substitution, pricing and reimbursement). These are forecasted using relevant data and analogues analysis, while assessing the implications for your brand.
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with
them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and
Wales. Number 8860726